Ost-müük Biogaia B - BIOGb CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 4.1 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025632% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | -0.018813% | ||||||||
Ööpäeva tasu aeg | 22:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | SEK | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | Sweden | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Biogaia AB ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Eelmine sulgemine* | 93.4 |
Avatud* | 93.3 |
Aastane muutus* | -81.37% |
Päeva ulatus* | 92.4 - 95.6 |
52 nädala ulatus | 68.88-125.60 |
Keskmine maht (10 päeva) | 85.91K |
Keskmine maht (3 kuud) | 1.89M |
Turukapitalisatsioon | 9.16B |
P/E suhtarv | 34.89 |
Ringluses olevad aktsiad | 100.98M |
Tulu | 1.04B |
EPS | 2.70 |
Dividendid (% kasumist) | 1.5414 |
Beeta | 0.72 |
Järgmine tuluaruande kuupäev | Feb 3, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Feb 1, 2023 | 93.4 | 1.5 | 1.63% | 91.9 | 93.9 | 91.8 |
Jan 31, 2023 | 90.9 | -0.1 | -0.11% | 91.0 | 91.6 | 90.8 |
Jan 30, 2023 | 91.6 | 0.5 | 0.55% | 91.1 | 91.6 | 90.2 |
Jan 27, 2023 | 91.7 | 0.8 | 0.88% | 90.9 | 92.2 | 90.3 |
Jan 26, 2023 | 90.3 | -2.3 | -2.48% | 92.6 | 93.0 | 90.3 |
Jan 25, 2023 | 92.6 | -0.1 | -0.11% | 92.7 | 93.4 | 91.5 |
Jan 24, 2023 | 93.5 | -0.9 | -0.95% | 94.4 | 95.0 | 93.4 |
Jan 23, 2023 | 94.5 | -0.4 | -0.42% | 94.9 | 95.1 | 94.0 |
Jan 20, 2023 | 93.3 | 0.7 | 0.76% | 92.6 | 94.1 | 92.2 |
Jan 19, 2023 | 92.0 | -3.0 | -3.16% | 95.0 | 95.4 | 92.0 |
Jan 18, 2023 | 95.1 | 0.9 | 0.96% | 94.2 | 95.7 | 93.0 |
Jan 17, 2023 | 94.3 | -1.2 | -1.26% | 95.5 | 96.1 | 91.6 |
Jan 16, 2023 | 94.5 | 1.8 | 1.94% | 92.7 | 95.8 | 92.3 |
Jan 13, 2023 | 92.5 | 2.8 | 3.12% | 89.7 | 92.8 | 88.2 |
Jan 12, 2023 | 89.0 | 2.4 | 2.77% | 86.6 | 90.1 | 86.0 |
Jan 11, 2023 | 87.0 | 0.0 | 0.00% | 87.0 | 88.4 | 86.0 |
Jan 10, 2023 | 86.9 | 1.2 | 1.40% | 85.7 | 87.1 | 84.5 |
Jan 9, 2023 | 85.4 | -0.6 | -0.70% | 86.0 | 87.1 | 84.5 |
Jan 5, 2023 | 84.6 | -0.3 | -0.35% | 84.9 | 85.9 | 82.5 |
Jan 4, 2023 | 85.0 | -1.0 | -1.16% | 86.0 | 88.7 | 84.2 |
Biogaia B Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Kogutulu | 534.696 | 615.003 | 741.87 | 768.347 | 747.077 | 785.11 |
Tulu | 534.696 | 615.003 | 741.87 | 768.347 | 747.077 | 785.11 |
Kulud, Kokku | 146.889 | 151.655 | 185.956 | 204.349 | 200.159 | 202.161 |
Brutokasum | 387.807 | 463.348 | 555.914 | 563.998 | 546.918 | 582.949 |
Kogu tegevuskulu | 335.259 | 381.17 | 464.511 | 525.836 | 518.927 | 531.373 |
Müük/Üldine/admin kulud, kokku | 127.33 | 147.786 | 179.783 | 207.058 | 196.289 | 233.221 |
Uuringud ja arendus | 63.532 | 75.324 | 98.776 | 103.164 | 102.84 | 102.865 |
Depreciation / Amortization | 1.934 | 1.768 | 1.945 | 3.765 | 3.296 | 4.364 |
Intressikulu (tulu) - neto majandustegevusest | -4.426 | 0.82 | -6.504 | 0 | 11.506 | |
Tulud majandustegevusest | 199.437 | 233.833 | 277.359 | 242.511 | 228.15 | 253.737 |
Intressitulud (kulu), muud tulud, neto | -3.256 | -0.73 | 0.641 | -0.252 | -0.567 | -1.025 |
Muud, neto | -0.122 | -0.192 | -0.405 | |||
Netotulu enne makse | 196.059 | 232.911 | 277.595 | 242.259 | 227.583 | 252.712 |
Netotulu pärast makse | 159.349 | 180.564 | 214.233 | 187.258 | 179.73 | 196.273 |
Vähemuse intress | 0.284 | 0 | 0.657 | 0.089 | 0 | 0 |
Netotulu enne erikulusid | 159.633 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Erakorralised kulud kokku | 67.935 | 0 | ||||
Netotulu | 227.568 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Arvestatav tulu, v a erikulud | 159.633 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Arvestatav tulu, koos erikuludega | 227.568 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Jaotamisele kuuluv netotulu | 227.568 | 180.564 | 214.89 | 187.347 | 179.73 | 196.273 |
Keskmine jaotamisele kuuluv aktsia kohta | 86.68 | 86.68 | 86.68 | 86.68 | 89.2403 | 100.963 |
Jaotatav EPS, v a erakorralised kulud | 1.84164 | 2.08311 | 2.47912 | 2.16136 | 2.014 | 1.944 |
Dividends per Share - Common Stock Primary Issue | 1.5 | 1.8 | 2 | 1.6 | 1.364 | 1.452 |
Jaotamisele kuuluv normaal-EPS | 1.84164 | 2.08311 | 2.47912 | 2.16136 | 2.014 | 2.04477 |
Other Operating Expenses, Total | 3.817 | 4.555 | 7.5 | 16.343 | -22.744 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Kogutulu | 201.975 | 203.131 | 173.841 | 206.163 | 283.855 |
Tulu | 201.975 | 203.131 | 173.841 | 206.163 | 283.855 |
Kulud, Kokku | 56.775 | 52.282 | 45.975 | 47.129 | 81.647 |
Brutokasum | 145.2 | 150.849 | 127.866 | 159.034 | 202.208 |
Kogu tegevuskulu | 137.73 | 133.908 | 106.662 | 153.073 | 188.56 |
Müük/Üldine/admin kulud, kokku | 58.943 | 51.71 | 45.567 | 78.763 | 83.098 |
Uuringud ja arendus | 27.179 | 28.091 | 19.718 | 30.479 | 24.904 |
Other Operating Expenses, Total | -5.167 | 1.825 | -4.598 | -3.298 | -1.089 |
Tulud majandustegevusest | 64.245 | 69.223 | 67.179 | 53.09 | 95.295 |
Intressitulud (kulu), muud tulud, neto | -0.197 | -0.134 | -0.238 | -0.456 | 2.072 |
Netotulu enne makse | 64.048 | 69.089 | 66.941 | 52.634 | 97.367 |
Netotulu pärast makse | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Vähemuse intress | 0 | 0 | 0 | 0 | |
Netotulu enne erikulusid | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Netotulu | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Arvestatav tulu, v a erikulud | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Arvestatav tulu, koos erikuludega | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Jaotamisele kuuluv netotulu | 50.443 | 54.711 | 52.844 | 38.275 | 76.297 |
Keskmine jaotamisele kuuluv aktsia kohta | 100.98 | 100.98 | 100.98 | 100.914 | 100.98 |
Jaotatav EPS, v a erakorralised kulud | 0.49953 | 0.5418 | 0.52331 | 0.37928 | 0.75557 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 1.452 | 0 |
Jaotamisele kuuluv normaal-EPS | 0.55803 | 0.5418 | 0.52331 | 0.41964 | 0.78583 |
- Aastas
- Kvartalis
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Käibevarad kokku | 385.34 | 454.337 | 494.415 | 452.438 | 1689.58 | 1752.08 |
Raha ja lühiajalised investeeringud | 243.082 | 310.856 | 289.794 | 218.814 | 1467.88 | 1484.68 |
Raha ja ekvivalendid | 243.069 | 305.856 | 284.962 | 213.831 | 1467.88 | 1484.68 |
Lühiajalised investeeringud | 0.013 | 5 | 4.832 | 4.983 | 0 | |
Laekumata arved, neto | 98.558 | 105.251 | 154.819 | 156.316 | 143.196 | 148.53 |
Accounts Receivable - Trade, Net | 92.206 | 96.832 | 142.009 | 129.763 | 101.658 | 128.152 |
Total Inventory | 40.479 | 32.612 | 44.213 | 68.445 | 72.277 | 102.737 |
Prepaid Expenses | 1.314 | 1.035 | 1.477 | 1.731 | 1.735 | 0 |
Other Current Assets, Total | 1.907 | 4.583 | 4.112 | 7.132 | 4.486 | 16.13 |
Total Assets | 488.978 | 576.112 | 659.973 | 665.9 | 1913.28 | 2128.05 |
Property/Plant/Equipment, Total - Net | 82.43 | 102.465 | 105.935 | 149.042 | 162.765 | 153.635 |
Property/Plant/Equipment, Total - Gross | 128.463 | 155.117 | 166.773 | 218.949 | 256.218 | 275.996 |
Accumulated Depreciation, Total | -46.034 | -52.654 | -60.84 | -69.909 | -93.453 | -122.361 |
Intangibles, Net | 0 | 45.85 | 52.558 | 50.322 | 48.086 | |
Long Term Investments | 10.775 | 9.971 | 0.043 | 0.044 | 0.039 | 22.272 |
Other Long Term Assets, Total | 10.433 | 9.339 | 8.43 | 6.518 | 5.279 | 2.757 |
Total Current Liabilities | 73.466 | 111.446 | 145.173 | 124.8 | 135.062 | 126.954 |
Accounts Payable | 16.951 | 20.893 | 34.009 | 28.491 | 48.046 | 42.313 |
Accrued Expenses | 25.381 | 40.887 | 57.349 | 53.913 | 48.723 | 56.399 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 31.134 | 49.666 | 53.815 | 34.83 | 30.093 | 19.342 |
Total Liabilities | 73.78 | 112.208 | 154.991 | 158.028 | 167.039 | 250.689 |
Total Long Term Debt | 0 | 0 | 0 | 17.254 | 20.7 | 10.4 |
Deferred Income Tax | 0.332 | 0.778 | 6.679 | 10.339 | 11.312 | 14.24 |
Minority Interest | -0.018 | -0.016 | 3.139 | 0.002 | 0.002 | 0.002 |
Total Equity | 415.198 | 463.904 | 504.982 | 507.872 | 1746.24 | 1877.36 |
Common Stock | 17.336 | 17.336 | 17.336 | 17.336 | 20.196 | 20.196 |
Additional Paid-In Capital | 20.096 | 43.662 | 43.662 | 21.831 | 1149.48 | 1154.01 |
Retained Earnings (Accumulated Deficit) | 377.766 | 402.906 | 443.984 | 468.705 | 576.564 | 703.161 |
Total Liabilities & Shareholders’ Equity | 488.978 | 576.112 | 659.973 | 665.9 | 1913.28 | 2128.05 |
Total Common Shares Outstanding | 83.7196 | 83.7196 | 83.7196 | 83.7196 | 98.0196 | 98.0196 |
Goodwill, Net | 5.3 | 5.3 | 5.3 | 149.227 | ||
Current Port. of LT Debt/Capital Leases | 7.566 | 8.2 | 8.9 | |||
Capital Lease Obligations | 17.254 | 20.7 | 10.4 | |||
Other Liabilities, Total | 5.633 | -0.037 | 99.093 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 1711.47 | 1705.69 | 1742.81 | 1752.08 | 1849.21 |
Raha ja lühiajalised investeeringud | 1486.77 | 1468.94 | 1529.74 | 1484.68 | 1571.69 |
Raha ja ekvivalendid | 1486.77 | 1468.94 | 1529.74 | 1484.68 | 1571.69 |
Other Current Assets, Total | 224.704 | 236.753 | 213.072 | 9.768 | 277.522 |
Total Assets | 1946.15 | 1935.85 | 1967.69 | 2128.05 | 2230.16 |
Property/Plant/Equipment, Total - Net | 151.581 | 148.076 | 143.72 | 153.635 | 153.261 |
Goodwill, Net | 5.3 | 5.3 | 5.3 | 149.227 | 152.73 |
Intangibles, Net | 49.763 | 49.204 | 48.645 | 48.086 | 47.713 |
Long Term Investments | 22.271 | 22.27 | 22.271 | 22.272 | 22.273 |
Other Long Term Assets, Total | 5.759 | 5.309 | 4.944 | 2.757 | 4.97 |
Total Current Liabilities | 120.658 | 123.594 | 104.057 | 126.954 | 153.018 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 120.658 | 123.594 | 104.057 | 19.342 | 153.018 |
Total Liabilities | 148.51 | 150.846 | 128.878 | 250.689 | 273.518 |
Total Long Term Debt | 0 | 0 | 0 | 10.4 | 0 |
Deferred Income Tax | 11.218 | 11.218 | 11.218 | 14.24 | 14.19 |
Minority Interest | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
Other Liabilities, Total | 16.632 | 16.032 | 13.601 | 99.093 | 106.308 |
Total Equity | 1797.64 | 1785 | 1838.81 | 1877.36 | 1956.64 |
Other Equity, Total | 1797.64 | 1785 | 1838.81 | 1877.36 | 1956.64 |
Total Liabilities & Shareholders’ Equity | 1946.15 | 1935.85 | 1967.69 | 2128.05 | 2230.16 |
Total Common Shares Outstanding | 98.0196 | 98.0196 | 98.0196 | 98.0196 | 98.0196 |
Laekumata arved, neto | 154.892 | ||||
Accounts Receivable - Trade, Net | 118.588 | ||||
Total Inventory | 102.737 | ||||
Accounts Payable | 42.313 | ||||
Accrued Expenses | 56.399 | ||||
Current Port. of LT Debt/Capital Leases | 8.9 | ||||
Capital Lease Obligations | 10.4 |
- Aastas
- Kvartalis
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netotulu/algväärtus | 194.275 | 232.991 | 277.359 | 242.511 | 228.15 | 253.737 |
Raha majandustegevusest | 147.929 | 222.615 | 183.12 | 147.855 | 221.256 | 221.875 |
Raha majandustegevusest | 7.074 | 6.573 | 7.546 | 15.593 | 20.53 | 27.241 |
Mittelikviidsed varad | -3.966 | 2.558 | 0.591 | 3.075 | -3.709 | 0.047 |
Cash Taxes Paid | 43.381 | 49.547 | 52.408 | 72.292 | 72.092 | 55.934 |
Makstud intressid | 0.124 | 0.401 | 0.694 | |||
Muutused tööjõus | -49.454 | -19.507 | -102.376 | -113.324 | -23.715 | -59.15 |
Tulu investeeringutelt | -9.611 | -26.643 | -47.301 | -39.024 | -16.075 | -126.967 |
Kapitalikulutused | -5.611 | -26.624 | -13.454 | -39.024 | -16.075 | -28.608 |
Muud rahavood investeeringutelt, kokku | -4 | -0.019 | -33.847 | 0 | -98.359 | |
Rahavood investeeringutelt | -124.311 | -132.421 | -158.728 | -181.09 | 1051.4 | -81.846 |
Total Cash Dividends Paid | -124.311 | -130.023 | -156.028 | -173.365 | -65.012 | -68.87 |
Aktsiate emiteerimine (tagasiost), neto | 0 | 1126.84 | 4.525 | |||
Muutused valuutakursside kõikumisest | 2.18 | -0.764 | 2.015 | 1.128 | -2.525 | 3.735 |
Rahaline kogumuutus | 16.187 | 62.787 | -20.894 | -71.131 | 1254.05 | 16.797 |
Rahavoogudesse investeerimine | -2.398 | -2.7 | -3.2 | -2.8 | -2.8 | |
Laenu väljastamine (kustutamine), neto | -4.525 | -7.632 | -14.701 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 64.245 | 133.468 | 200.647 | 253.737 | 95.295 |
Cash From Operating Activities | 41.892 | 97.655 | 165.61 | 221.875 | 93.065 |
Cash From Operating Activities | 10.363 | 15.855 | 22.106 | 27.241 | 6.049 |
Non-Cash Items | -0.189 | 1.414 | -2.786 | 0.047 | -1.136 |
Cash Taxes Paid | 17.196 | 35.88 | 52.731 | 55.934 | 17.512 |
Changes in Working Capital | -32.527 | -53.082 | -54.357 | -59.15 | -7.143 |
Cash From Investing Activities | -23.269 | -24.041 | -36.865 | -126.967 | -5.081 |
Capital Expenditures | -23.269 | -24.041 | -36.865 | -28.608 | -5.081 |
Cash From Financing Activities | -1.4 | -72.551 | -72.07 | -81.846 | -2.211 |
Financing Cash Flow Items | 0 | -2.8 | -2.8 | -2.8 | 0 |
Total Cash Dividends Paid | 0 | -68.87 | -68.87 | -68.87 | 0 |
Issuance (Retirement) of Stock, Net | 0 | 2.138 | 4.989 | 4.525 | -0.206 |
Issuance (Retirement) of Debt, Net | -1.4 | -3.019 | -5.389 | -14.701 | -2.005 |
Foreign Exchange Effects | 1.664 | -0.011 | 5.178 | 3.735 | 1.24 |
Net Change in Cash | 18.887 | 1.052 | 61.853 | 16.797 | 87.013 |
Other Investing Cash Flow Items, Total | -98.359 | 0 |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com GroupKauplejad
Igakuiste aktiivsete klientide arv
Igakuine investeerimise maht
Igakuiselt välja võetud
Kauplemiskalkulaator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Biogaia Company profile
Ettevõttest Biogaia B
Biogaia AB on Rootsis asuv tervishoiuettevõte, mis tegeleb probiootiliste toodete arendamise ja müügiga. Ettevõte arendab, turustab ja müüb probiootilisi tooteid, millel on dokumenteeritud kasu tervisele. Tooted põhinevad peamiselt piimhappebakteri Limosilactobacillus reuteri erinevatel tüvedel. Ettevõtte tegevus jaguneb kolmeks segmendiks: Pediaatriasegment tilgad, soolestiku tervisetabletid, suuõõne rehüdratsioonilahus (ORS) ja kultuurid, mida kasutatakse litsentsisaajate toodete koostisosana; täiskasvanute tervisesegment (soolestiku tervisetabletid, suuõõne tervisetabletid ja kultuurid litsentsisaajate piimatoodete koostisosana) ja muu (litsentsitasud seoses arendusprojektidega, tulu tütarettevõtte CapAble pakendilahendustest jne). Ettevõte tegutseb kogu maailmas.
Industry: | Biopharmaceuticals |
Kungsbroplan 3
STOCKHOLM
STOCKHOLM 112 27
SE
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 485,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com